California Governor Gavin Newsom is seriously considering a 2028 presidential run, but will wait until after the 2026 midterms to make a final decision.
Novartis to acquire Avidity Biosciences for $12 billion, bolstering its neuroscience pipeline with late-stage programs.
California Governor Gavin Newsom is seriously considering a 2028 presidential run, but will wait until after the 2026 midterms to make a final decision.
Novartis to acquire Avidity Biosciences for $12 billion, bolstering its neuroscience pipeline with late-stage programs.